Wallstreet Hotties of the Day: Cirrus Logic Inc. (NASDAQ:CRUS), Cellectar Biosciences, Inc. (NASDAQ:CLRB)

Cirrus Logic Inc. (NASDAQ:CRUS)

The shares of Cirrus Logic Inc. (NASDAQ:CRUS) started off the last trading session with the price of $44.87 while closing the day with the price of $42.69. The shares of Cirrus Logic Inc. (NASDAQ:CRUS) Fell -4.69% with the Loss of -2.18 points.

The shares of Cirrus Logic Inc. (NASDAQ:CRUS) traded with the day volume of 1.87 Million shares whereas its average trading volume is 1.23 Million.

While analyzing the past performance of the stock we can see that the shares of Cirrus Logic Inc. (NASDAQ:CRUS) Loss -5.43% in the last week while rising 0.31% in the last month. Past quarter performance shows the red light with -13.88%. The semi-annual and annual performance shows -26.21% and -26.94% respectively.

Some critical values of the shares of Cirrus Logic Inc. (NASDAQ:CRUS) to be discussed here are: the beta which shows the value at 0.15 while Average True Range of Cirrus Logic Inc. (NASDAQ:CRUS) demonstrate the value at 1.57. The weekly and monthly volatility of the shares of Cirrus Logic Inc. (NASDAQ:CRUS) are indicated at 4.23% and 3.32%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 40.15.

While studying the financial position of the shares of Cirrus Logic Inc. (NASDAQ:CRUS), we can see that the Market capitalization of the company is at 2.71 Billion. The shares outstanding for the company is 63.45 Million and the shares float stands at 62.87 Million. The income of the company stand at 242.9 Million while the sales stand at 1.56 Billion.

Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at 3.66, Price to Earnings or P/E is at 11.65, Price to Sales P/S show the value of 1.74, the Return on Asset ROA stood at 0.129 and the Return on Equity ROE depicted at 0.157 while Return on Investment ROI is at 0.217.


Cellectar Biosciences, Inc. (NASDAQ:CLRB)

Cellectar Biosciences, Inc. (NASDAQ:CLRB) started its previous trading session at $1.32 and closed at $1.19 showing a Rise of 1.71 Percent.

The Company traded with an average Volume of 274.15 Million whereas, its Day Volume stood at 1.87 Million.

Looking at the performance of the stock, Cellectar Biosciences, Inc. (NASDAQ:CLRB) Loss -0.83% in the last week in its shares price and -2.46% in the last month. Quarterly performance shows a green of 6.25 Percent while Semi-Annual and Annual performances shows a -33.52 and -49.36 percent respectively.

Beta for Cellectar Biosciences, Inc. (NASDAQ:CLRB) stands at 0.75 while the ATR (average true range) is at 0.08. The Stock’s Weekly and Monthly Volatility is 8.14% and 6.39% respectively showing a RSI value of 51.55.

While studying the financial position of the shares of Cellectar Biosciences, Inc. (NASDAQ:CLRB), we can see that the Market capitalization of the company is at 18.81 Million. The shares outstanding for the company is 15.81 Million and the shares float stands at 14.18 Million.

The Company generated an income of -12100000 and the sales of 0 in the Trailing Twelve Months period.

While analyzing the stock from technical aspects, Diluted Earnings per share stands at $-1.07 a share. P/E (price to earnings) and P/S (price to sales) values are 0 and 0 respectively.

The Return on Assets stands at -0.909, ROE shows a value of -1.076 and ROI for Cellectar Biosciences, Inc. (NASDAQ:CLRB) is 0 as of Trailing Twelve Months period.

The following two tabs change content below.

Eldred Matthew

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

View all contributions by

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a Comment